SEC Filing Analysis: EXACT SCIENCES CORP (EXAS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The SVP & General Counsel executed a small, pre-planned sale of common stock valued at approximately $105,120 under a Rule 10b5-1 trading plan.
• Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to have any market impact.

Company Information

Field	Value
Company	EXACT SCIENCES CORP
Ticker Symbol	EXAS
CIK	0001124140
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	Herriott James
CIK	0001957680
Title/Position	SVP, General Counsel & Sec
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-04
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	1,500
Price Per Share	$70.08
Total Value	$105,120
Shares Owned After	14,141 (Direct and Indirect)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$105,120
% of Market Cap	0.0008%
Shares Transacted	1,500
% of Shares Outstanding	0.0008%
Post-Transaction Ownership	14,141 shares (0.0075% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $13.19 billion, this $105k transaction is financially insignificant.
• Ownership Concentration: The insider's total holdings of 14,141 shares represent a very small fraction (0.0075%) of the total shares outstanding, indicating low ownership concentration.
• Transaction Significance: The sale represents less than 0.001% of both the market cap and shares outstanding, categorizing it as a routine transaction with low significance. The sale constituted approximately 9.6% of the insider's prior common stock holdings.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is extremely small relative to the company's size and was executed under a pre-scheduled 10b5-1 plan, indicating it was not based on recent material non-public information.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to impact daily trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales by executives for personal financial management are common and typically do not influence market sentiment.

Additional Context

Special Circumstances

• 10b5-1 Plan: The filing's footnote confirms this sale was made pursuant to a Rule 10b5-1 trading plan established on March 3, 2025. This reduces the likelihood that the trade was timed based on inside information.